iShares iBoxx $ High Yield Corporate Bond ETF vs ResMed Inc. — how do they compare? iShares iBoxx $ High Yield Corporate Bond ETF trades at $79.65, while ResMed Inc. trades at $197.45 (market cap $28.81B). The key difference: ResMed Inc. pays a 1.21% dividend while iShares iBoxx $ High Yield Corporate Bond ETF pays none, and iShares iBoxx $ High Yield Corporate Bond ETF is trading nearer its 52-week high, ResMed Inc. nearer its low. Which is the better fit depends on your goals.
| HYG | RMD | |
|---|---|---|
Sector | Fixed Income | Health |
52-Week High | $81.32 | $293.73 |
52-Week Low | $78.72 | $182.82 |
Market Cap | — | $28.81B |
Enterprise Value | — | $27.99B |
Dividend Yield | — | 1.21% |
Trailing returns across standard periods
Latest headlines on both assets
HYG is the world's largest high-yield bond ETF, tracking the Markit iBoxx USD Liquid High Yield Index. It provides liquid exposure to non-investment grade corporate debt, with 2026 top holdings including Cloud Software Group and Medline.
Read more on HYG →ResMed is one of the largest respiratory care device companies globally, primarily developing and supplying flow generators, masks and accessories for the treatment of sleep apnea. Increasing diagnosis of sleep apnea combined with ageing populations and increasing prevalence of obesity is resulting in a structurally growing market. The company earns roughly two thirds of its revenue in the Americas and the balance across other regions dominated by Europe, Japan and Australia. Recent developments and acquisitions have focused on digital health as ResMed is aiming to differentiate itself through the provision of clinical data for use by the patient, medical care advisor and payer in the out-of-hospital setting.
Read more on RMD →